Glaxosmithkline | DÍVIDA



Debt Alterar Data
AbbVie USD 67.14B 3.94B 2024-12
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 106M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
Indivior 329M 4M 2025-03
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.26B 828M 2024-12
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.63B 9.4M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
Prestige Brands USD 996.95M 54.86M 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.84T 211.04B 2024-12
Teva Pharmaceutical Industries USD 16.65B 1.43B 2025-03
Zoetis USD 6.58B 7M 2025-03



Glaxosmithkline DÍVIDA - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.